England
UK Government to offer HPV vaccine to men who have sex with men
February 6, 2018Manufacturing and Production, Medical Communications, Research and Development England, HPV, UK, human papillomavirus, pharma, vaccination
The UK Government has confirmed a national vaccination programme that will provide access for men who have sex with men(MSM) …
Report finds variation in quality of care in GP practices across England
September 21, 2017Medical Communications : Pharma, England, GP, NHS, biotech, drugs, pharma, pharmaceutical
Depending on your interpretation of results from the Care Quality Commission’s (CQC) recent report on the standard of care provided …
Wales approve pancreatic cancer drug for use despite NICE rejection in England
March 18, 2016Medical Communications, Research and Development Abraxane, Celgene, England, NHS, NICE, Wales, approval
Celgene (Nasdaq: CELG) has announced that Abraxane, in combination with gemcitabine, will continue to be an available treatment option for …
NHS in England is ‘deteriorating’
March 26, 2015Sales and Marketing Conservatives, England, Labour, NHS, coalition, election, government, liberal
Leading UK healthcare think tank The King’s Fund has published its second report on the NHS under the present government …
NHS launches mental health apps library
March 25, 2015Medical Communications, Sales and Marketing England, NHS, apps, choices, digital, kitemark, online
NHS England has launched a directory of digital services it endorses for the treatment of mental health, in the first …
NHS backtracks on Cancer Drugs Fund de-listings
March 12, 2015Sales and Marketing Afinitor, CDF, Cancer Drugs Fund, England, Halaven, NHS, Novartis, everolimus
NHS England is expected to perform a U-turn on several decisions to remove treatments from the cancer drugs fund when …
UK government spends £300 million on dementia
February 23, 2015Research and Development, Sales and Marketing Cameron, England, NHS, dementia, investment, research
UK prime minister David Cameron has said the government is to invest more than £300m into dementia research and that …
NHS plans bashed over cancer and heart disease
December 24, 2014Research and Development, Sales and Marketing Cancer, England, NHS, Simon Stevens, funding, heart
Hundreds of healthcare experts have signed an open letter to NHS chief executive Simon Stevens calling for him to scrap …
Half of England on prescription drugs
December 11, 2014Sales and Marketing England, HSCIC, NHS, doctors, prescribing, prescriptions
Almost half of the people in England are taking regular prescription medicines according to a new report by the Health …
NICE aims for earlier cancer diagnosis
November 20, 2014Sales and Marketing Cancer, England, NHS, NICE, OECD, UK, baker
NICE is updating its guidance in a bid to help doctors spot the signs and symptoms of cancer as part …
NHS Better Care Fund lacks guidance, says watchdog
November 12, 2014Sales and Marketing England, NHS, UK, better care fund, nao
A much-lauded project to reduce unnecessary hospital visits and shift care into the community will fall well short of its …
NICE backs world’s most expensive medicine
September 4, 2014Sales and Marketing AGNSS, Alexion, England, NICE, aHUS, solaris
In a U-turn on its previous guidance NICE is now recommending that the £330,000 rare disease drug Soliris should be …
Unison warns of ‘dangerous’ £1 billion NHS tender
July 4, 2014Sales and Marketing CCG, England, NHS, commissioning, unison
A row is bubbling over the provision of health services in Staffordshire after a trade union accused four NHS clinical …
NICE launches VBA consultation
March 27, 2014Sales and Marketing Dillon, England, NHS, NICE, VBP, catchpole, pars, vba
NICE has today launched its consultation into how value-based assessment of drugs will work in practice, which will run for …
NHS England delays patient data roll-out
February 19, 2014Medical Communications, Sales and Marketing England, HSCIC, NHS, care data, care.data, data, patients
The giant NHS database that could allow pharma firms to buy into patient records will now not be launched until …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
